Loading...
Uploaded by jenniferschenker on Mar 15, 2009
During an interview with Informilo 23andme co-founder Linda Avey talks about why the company is zeroing in on Parkinson's Disease, the evolution of personalized medicine and the firm's international expansion plans
Science & Technology
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (1)